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Off-loading the diabetic foot for ulcer prevention
and healing
Peter R. Cavanagh, PhD, DSc,a and Sicco A. Bus, PhD,b Seattle, Wash; and Amsterdam, The Netherlands
Background: Retrospective and prospective studies have shown that elevated plantar pressure is a causative factor in the
development of many plantar ulcers in diabetic patients and that ulceration is often a precursor of lower extremity
amputation. In this article, we review the evidence that relieving areas of elevated plantar pressure (off-loading) can
prevent and heal plantar ulceration.
Results: There is no consensus in the literature concerning the role of off-loading through footwear in primary or
secondary prevention of ulcers. This is likely due to the wide diversity of intervention and control conditions tested, the
lack of information about off-loading efficacy of the footwear used, and the absence of a target pressure threshold for
off-loading. Uncomplicated plantar ulcers should heal in 6 to 8 weeks with adequate off-loading. The total contact cast
and other nonremovable devices are most effective because they eliminate the problem of nonadherence to recommen-
dations for using a removable device. Conventional or standard therapeutic footwear is not effective in ulcer healing.
Recent United States and European surveys show a large discrepancy between guidelines and clinical practice in
off-loading diabetic foot ulcers. Many clinics continue to use methods that are known to be ineffective or have not been
proven effective, while ignoring methods that have been demonstrated to be efficacious.
Conclusions: A number of strategies are proposed to address this situation, notably the adoption and implementation of
recently established international guidelines, which are evidence-based and specific, by professional societies in theUnited
States and Europe. Such an approach would change the often poor current expectations for healing diabetic plantar
ulcers. ( J Vasc Surg 2010;52:37S-43S.)WHAT IS OFF-LOADING AND HOW CAN IT BE
MEASURED?
In the sensate foot, for example in a patient with rheuma-
toid arthritis, relieving the local pressure (off-loading) at pain-
ful regions of the foot is both driven and evaluated by the
patient’s perceived pain.1 However, up to about 50% of
people with diabetes mellitus (depending on ethnicity2)
will eventually have loss of sensation in the feet secondary to
peripheral neuropathy that is sufficient to allow them to
injure the soft tissues of the plantar surface, a condition that
has been termed loss of protective sensation.3 These areas
need to be off-loaded, but because the patient has inade-
quate sensation, his or her feedback is not useful in judging
whether or not pressure relief has been obtained.4
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doi:10.1016/j.jvs.2010.06.007The design of footwear and in-shoe devices to off-load
at-risk areas of the diabetic foot has traditionally been
considered to be an art rather than a science. This is despite
the fact that a report of one of the first studies to actually
measure the pressure relief from therapeutic footwear was
published almost 50 years ago.5 Pressure measurement
inside footwear is now more widespread, although because
of economic and reimbursement issues, it is more common
in a research setting than in clinical practice. An example of
what the technique can demonstrate is shown in Fig 1. The
substantial difference in off-loading, which can be seen
between the two footwear conditions, is apparent, but the
practitioner would not be able to determine this difference
without the benefit of the measuring device. This is one of
the reasons why off-loading the diabetic foot is so difficult
and prone to failure.
WHY IS OFF-LOADING NEEDED?
Retrospective and prospective studies have shown that
elevated plantar pressure is a cause of the development of
plantar ulcers in diabetic patients6-8 and that ulceration is
often a precursor of lower extremity amputation.9 Many
structural abnormalities in the foot have been associated
with increased levels of plantar pressure.10 In a person with
diabetes, claw-toe deformity and Charcot neuroarthropa-
thy are among the most important abnormalities that may
cause significant disruption to the architecture of the
foot11,12 and elevated local foot pressures.13,14 The com-
bination of foot deformity, loss of protective sensation, and
inadequate off-loading leads to tissue damage and ulcer-
ation. Once an ulcer has formed, studies described below
indicate that unless the ulcerated area is off-loaded, healing
may be chronically delayed, even in an adequately perfused
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high— 40% in a median 4 months in one recent study15—
showing the need for continuous off-loading in these pa-
tients.
In this article, we will demonstrate that effective off-
loading of diabetic feet is important for ulcer healing and
the prevention of ulcer recurrence. There is not yet suffi-
cient evidence to support primary prevention of ulcers by
off-loading, although clinical opinion strongly favors such
an approach. Many new potential solutions for healing
diabetic foot ulcers—such as topically applied growth fac-
tors, bioengineered skin, and stem cells—have been pro-
posed. What all solutions have in common is that they
require a mechanical environment that will not destroy the
healing construct. This must be achieved by some device
that will effectively remove mechanical stress from the
wound and its immediate environment. The effectiveness
of off-loading must be judged both by the relief of stress
and by the patient’s adherence to the treatment.
THE EVIDENCE BASE: WHAT WORKS AND
WHAT DOES NOT WORK?
Pressure off-loading. Total contact casts (TCCs) and
removable walkers have been shown to be extremely effec-
tive in off-loading the diabetic foot, with reported peak
pressure reduction in the forefoot up to 87% compared
with a control condition (Fig 2).16-19 This effect may be
achieved, among other mechanisms, by limiting ankle mo-
tion and redistributing load to the device itself.20 For these
reasons, devices that only extend to the ankle, such as cast
shoes and forefoot off-loading shoes, may be less effective
in off-loading the foot than devices that extend above the
ankle, as do TCCs and walkers. Reported off-loading values
Fig 1. A, Peak plantar pressure distribution shown for
experienced by each area of the foot through the suppo
inside the shoe of the same patient is shown while (B) a fl
used. The red and purple colors represent the areas with
of high-pressure regions identified during barefoot walkfor such devices range from 44% to 64% compared withcontrol.18,19,21,22 Various therapeutic footwear designs
can effectively off-load at-risk foot regions. Among these
designs, rocker-bottom outsoles, custom-made insoles,
and some shoe inserts (eg, metatarsal pads and medial arch
supports) may reduce forefoot peak pressure between 16%
and 52% compared with control.18,23-28 The design and
placement of such devices is critical, however, and difficult
to establish without pressure.
The surgical approaches of Achilles tendon lengthen-
ing and liquid silicon injections under the metatarsal heads
may only temporarily reduce pressure underneath the fore-
foot.29,30 Callus removal can reduce pressures by as much
as 30%, although the durability of such relief is un-
known.31,32 Different interventions exhibit a great varia-
tion in off-loading capacity (Fig 2), and this likely influ-
ences their efficacy in preventing or healing foot ulcers in
diabetic patients.
Ulcer healing. The largest evidence base on off-loading
available is for the treatment of primarily uncomplicated
neuropathic plantar foot ulcers (Fig 3). A number of differ-
ent metrics are used in wound healing studies to character-
ize progress toward healing. These include percentage of
wound closure in a given time and time to complete heal-
ing. It is generally assumed that time to complete healing is
the most important consideration in clinical practice be-
cause this affects treatment costs and, presumably, lowers
the risk for infection.
Several randomized controlled trials (RCTs) have
shown that the TCC is more effective than removable
devices, both in healing proportions and time to heal-
ing.33-36 One recent RCT showed similar healing rates
between the TCC and an ankle-high removable walker.37 A
meta-analysis of 11 studies using the TCC33,34,38-46
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vate communication). These ulcers had existed for an aver-
age of 282 days before treatment was initiated. Adverse
effects with TCCs may occur, however, including reduced
activity level, difficulty with sleeping or driving a car, and
Fig 2. The off-loading capacity of different modalities u
ulcers is expressed as percentage of peak pressure reducti
condition. The lighter bars show the range in measured
Fig 3. Histogram showing the proportion of healed ulc
expressed as a number of days (dark gray bars) for di
neuropathic plantar foot ulcers in diabetic patients. The
number of studies on which the bars showing percentagiatrogenic ulcers due to poor casting. Alternatively, belowthe knee removable walkers that have been made nonre-
movable may be as effective as TCCs and more effective
than standard removable walkers in healing plantar foot
ulcers.47-49
Ulcer healing using removable devices is complicated
or the prevention and treatment of diabetic plantar foot
the first metatarsal head region compared with a control
pressure reduction over different studies.
pressed as a percentage (black bars) and time to healing
t off-loading modalities used to treat noncomplicated
gray bars show the range found in different studies. The
ling are based is also indicated.sed f
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used their prescribed removable device for an average of
only 29% of their total daily number of steps.50 This may
explain the lower effectiveness of removable devices and
points to the importance of continued pressure relief to
promote healing. Half-shoes, forefoot off-loading shoes,
and cast shoes may be effective in healing neuropathic
forefoot ulcers (healing proportions, 58%-91%), although
their efficacy requires confirmation in prospective tri-
als.34,51-54 Conventional or standard therapeutic footwear
is not effective in ulcer healing, and the role of custom
footwear in this context is not yet clear.55
Several prospective controlled studies have shown that
surgical interventions such as Achilles tendon lengthening,
metatarsal-phalangeal joint arthroplasty, and metatarsal
head resection may have only limited additional value in
ulcer healing compared with conservative treatment.56-60
Neuroischemic or infected wounds can also be treated with
off-loading, although success rates are much lower than for
purely neuropathic wounds.61 In summary, the data on
ulcer healing support the use of nonremovable off-loading
modalities, whereas the role of certain removable devices
and surgical procedures requires further definition in pro-
spective controlled studies.
Ulcer prevention. Several prospective studies have
shown a beneficial effect of the use of therapeutic footwear
compared with standard footwear in preventing ulcer re-
currence.62-65 However, one RCT showed no effect.66
These contrasting results are likely due to the wide diversity
of intervention and control conditions tested and the lack
of information about off-loading efficacy of the footwear
used. This lack of standardization complicates the compar-
ison of studies and limits the definition of the role of special
footwear in ulcer prevention. In this context, a recent
prospective 5-year analysis on the use of a previously de-
fined footwear prescription algorithm67 showed much
lower primary and secondary ulceration rates (21%) com-
pared with the rates in the preceding 5 years in the same
study center (70%). This demonstrates the usefulness of
such a structured approach for ulcer prevention.68 Surgical
interventions may reduce ulcer recurrence rates in selected
patients compared with conservative treatment.56-59 How-
ever, complications with these procedures may occur, such
as transfer ulcers and impaired balance during walking.69,70
Overall, the evidence base to support the safe use of thera-
peutic footwear and surgical procedures for ulcer preven-
tion is still weak,71,72 although some recent studies show
promising results in this regard.
We do not yet know the exact pressure threshold that
will prevent plantar tissue damage from occurring. Our
group recently examined patients who had remained healed
after plantar ulceration and found a mean pressure of
approximately 200 kPa at the prior ulcer site.73 It may be
that such a threshold is unique to each individual, but the
200 kPa value can serve as a goal for plantar off-loading
until better evidence is available.
Clinical recommendations. Efforts have recently been
made by the International Working Group on the DiabeticFoot to develop specific evidence-based guidelines on the
use of footwear and off-loading for ulcer prevention and
healing in the diabetic foot.72,74 Recommendations for the
use of off-loading in treating noncomplicated neuropathic
plantar foot ulcers are:
● Relieving pressure on ulcers should always be a part of
the treatment plan.
● TCCs and nonremovable walkers are the preferred
interventions; however, the clinician should be aware
of possible adverse effects of these devices.
● Forefoot off-loading shoes or cast shoes may be used
when above the ankle devices are contraindicated or
not tolerated by the patient.
● Conventional or standard therapeutic footwear should
not be used since many other devices are more
effective.
Recommendations for the use of off-loading in ulcer
prevention in patients with an at-risk foot at-risk are:
● Regular callus removal should be provided by a skilled
health care professional.
● Patients should be urged to not walk barefoot at any
time.
● Therapeutic footwear, including a custom-molded in-
sole in a shoe with adequate depth, is the preferred
intervention.
Although surgical procedures may be effective for ulcer
healing or secondary prevention in selected patients, more
studies are needed to better define the role of surgery
compared with conservative treatment before it can be
recommended for widespread use.
DISCUSSION
We have presented strong evidence that uncomplicated
plantar ulcers can be healed in approximately 6 to 8 weeks.
This time frame is in sharp contrast to reported clinical
experience in the standard-of-care arms of U.S. clinical
trials in which only 24% and 31% of uncomplicated ulcers
were healed after 12 and 20 weeks, respectively.75 We
believe that inadequate use of off-loading explains this
difference. The guidelines discussed above are clear: non-
removable off-loading is the gold standard. But Wu et al76
found that 41% of 895 U.S. clinics responding to a survey
attempted to off-load patients with shoes, whereas 2%
used TCCs. Similarly, Fife et al77 reported only 6% of ulcer
patients received a TCC. However, among those patients
who received it, the average cost of treatment was half as
much as the cost incurred by patients who did not. In
Europe, the situation is not markedly different. Prompers et
al78 found that an average of only 35% (range 0%-68%) of
plantar foot ulcers were treated with casting in 14 special-
ized centers across the continent. A large discrepancy exists
between guidelines and clinical practice in off-loading dia-
betic foot ulcers.
How can this gap between recommendations and prac-
tice be bridged? One solution would be for professional
societies to help change the expectations among their
JOURNAL OF VASCULAR SURGERY
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to heal. Societies such as the American Podiatric Medical
Association and the Society for Vascular Surgery could also
formally adopt the international guidelines,74 which are
presently not well known in the United States. Such lack of
guidelines leads to heterogeneity of treatment that does not
benefit the patient. Many providers resist guidelines be-
cause, as they correctly point out, every patient is unique
and many additional intrinsic and extrinsic factors such as
technical difficulty, time of application, cost-effectiveness,
and reimbursement issues affect the choice of treatment.
We believe that poor off-loading is poor treatment, regard-
less of the constellation of other factors that must be
considered.
Previous recommendations may have been too general,
but recent evidence-based guidelines are specific and sup-
port implementation. In addition, in the same way that
decubitus ulcers, hip fractures, and six other “reasonably
preventable” conditions that occur after admission to the
hospital are not reimbursed in the United States by Medi-
care, the future may bring a similar change in the burden of
financial responsibility for what have traditionally been
called “nonhealing” neuropathic ulcers.
Many ulcers are indeed complicated by such factors as
infection and vascular disease,79,80 and the same expecta-
tions for time to heal cannot be applied to infected neurois-
chemic wounds. But off-loading is still important in such
complex wounds—perhaps even more important—because
of the enhanced risk of limb loss in these patients.
An additional barrier to appropriate prescription may
be that some practitioners are not trained to specify appro-
priate footwear interventions and may resist referring pa-
tients to qualified specialists. Establishing a good relation-
ship with qualified providers of therapeutic footwear and
orthotic interventions is an important component of com-
prehensive care for the diabetic foot. If a provider does not
have such expertise in-house, then locating a qualified
individual, perhaps with the help of specialized societies
(such as the Pedorthic Footwear Association in the United
States, www.pedorthics.org), should be considered.
Another major advance for off-loading the diabetic foot
for ulcer prevention and healing would be a requirement
that measurable and effective pressure reduction should
result from all prescribed interventions and that preferably
such pressure reduction be optimal (see Fig 1). Require-
ments for demonstrated efficacy have recently been intro-
duced in Germany. This will not be possible at every
treatment location because of cost, but specialized centers
should consider adding the capability for pressure measure-
ment to their prescription approach.
Current clinical practice includes several modalities for
healing diabetic foot ulcers that may be effective, although
no evidence base for their use now exists. We strongly urge
clinicians and researchers to prove the effectiveness of these
devices to support their use in clinical practice.
Documented pressure reduction is, of course, necessary—
but not sufficient—for healing or preventing foot ulcers.
Approaches that force adherence to off-loading in ulcertreatment by the application of some nonremovable device
must be given consideration in all cases where there is no
contraindication. Considerations for preventing ulcer re-
currence are somewhat different, although no less impor-
tant. Ulcer-free survival is poor,15 and a major challenge
that needs to be faced is a reduction of the number of ulcer
recurrences. Nonremovable devices cannot be used, and a
behavioral intervention combined with footwear that effec-
tively off-loads previously injured regions is required.
Unfortunately, effective strategies to increase adher-
ence have not yet been well established. The provider can
increase the chance that the interventions will be used by
providing attractive footwear and by accepting the fact that
outdoor therapeutic shoes (the typical prescription) are
unlikely to be worn at home. The provision of off-loading
sandals or slippers may reduce barefoot walking at home,
but currently it is likely the patient will have to bear the cost
of the additional footwear. If future studies can show a
reduction in reulceration when multiple types of footwear
are dispensed, this would be a powerful rationale to petition
for change in reimbursement policies. Currently, Medicare
allows only one pair of shoes and three pairs of insoles per
calendar year, and insurance companies in Europe generally
do not reimburse multiple types of footwear in the same
calendar year.
CONCLUSION
We have presented the evidence for the role of off-
loading in the prevention and treatment of plantar ulcers in
the diabetic foot. We point out that there is a gap between
evidence-based guidelines and current practice, particularly
regarding the use of nonremovable off-loading devices to
heal uncomplicated neuropathic ulcers. A number of strat-
egies are proposed to address this gap, notably the adoption
and implementation of recently established evidence-based
and specific international guidelines by professional societ-
ies in the United States and Europe. Such an approach
would change the current poor expectations for healing of
diabetic plantar ulcers.
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